CVS HEALTH CORP (CVS)
US1266501006 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.20B | 12.95B | 9.41B | 7.85B | 5.68B | |||
| Marketable Securities | 3.26B | 2.78B | 3.12B | 3.00B | 2.37B | |||
| Receivables | 35.23B | 27.28B | 24.43B | 21.74B | 19.62B | |||
| Inventories | 18.02B | 19.09B | 17.76B | 18.50B | 17.52B | |||
| Other Current Assets | 3.15B | 3.54B | 5.29B | 5.28B | 5.11B | |||
| Total Current Assets | 67.86B | 65.63B | 60.01B | 56.37B | 50.30B | |||
| Non-Current Assets | ||||||||
| PPE Net | 30.43B | 30.75B | 32.02B | 33.34B | 32.90B | |||
| Investments And Advances | 23.02B | 21.10B | 23.02B | 20.81B | 17.31B | |||
| Goodwill | 91.27B | 78.15B | 79.12B | 79.55B | 79.75B | |||
| Intangibles | 29.23B | 24.80B | 29.03B | 31.14B | 33.12B | |||
| Other Non-Current Assets | 7.91B | 7.85B | 9.80B | 9.51B | 9.06B | |||
| Total Non-Current Assets | 181.87B | 162.64B | 172.99B | 174.35B | 172.15B | |||
| TOTAL ASSETS | 249.73B | 228.28B | 233.00B | 230.72B | 222.45B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 200.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.77B | 1.78B | 4.21B | 5.44B | 3.78B | |||
| Accrued Expenses | 23.78B | 20.35B | 19.23B | 15.81B | 13.66B | |||
| Accounts Payable | 49.82B | 44.40B | 38.68B | 34.87B | 30.97B | |||
| Other Current Liabilities | 2.62B | 2.89B | 5.69B | 5.90B | 4.89B | |||
| Total Current Liabilities | 79.19B | 69.42B | 67.81B | 62.02B | 53.30B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 58.64B | 50.48B | 51.97B | 59.21B | 64.70B | |||
| Deferred Taxes/Income | 4.31B | 4.02B | 6.27B | 6.79B | 7.29B | |||
| Other Non-Current Liabilities | 30.95B | 32.59B | 31.57B | 33.00B | 32.98B | |||
| Total Non-Current Liabilities | 94.08B | 87.39B | 90.12B | 99.31B | 105.28B | |||
| TOTAL LIABILITIES | 173.27B | 156.81B | 157.92B | 161.33B | 158.59B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 61.60B | 56.40B | 54.91B | 49.64B | 45.11B | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Minority Interest | 151.00M | 284.00M | 318.00M | 299.00M | 309.00M | |||
| Common Shares | 48.99B | 48.19B | 47.38B | 46.51B | 45.97B | |||
| Treasury Stock | -33.84B | -31.86B | -28.17B | -28.18B | -28.23B | |||
| Other Shareholders' Equity | 132.00M | 255.00M | 187.00M | 200.00M | 245.00M | |||
| Shares Outstanding | 1.29B | 1.30B | 1.32B | 1.31B | 1.30B | |||
| Tangible Book Value per Share | -34.20 | -24.22 | -25.02 | -31.53 | -37.64 | |||
| Total Shareholders' Equity | 76.46B | 71.47B | 75.08B | 69.39B | 63.86B | |||
| TOTAL LIABILITIES AND EQUITY | 249.73B | 228.28B | 233.00B | 230.72B | 222.45B | |||
| Statistics | ||||||||
| Debt/Equity | 0.77 | 0.71 | 0.69 | 0.85 | 1.01 | |||
| Current Ratio | 0.86 | 0.95 | 0.88 | 0.91 | 0.94 | |||
| Return On Assets (ROA) | 3.34% | 1.89% | 3.43% | 3.11% | 2.98% | |||
| Return On Equity (ROE) | 10.91% | 6.03% | 10.66% | 10.35% | 10.39% | |||
| Return On Invested Capital (ROIC) | 6.58% | 7.64% | 6.87% | 6.17% | 5.49% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.06% | 8.48% | 7.43% | 6.60% | 5.77% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 28.99% | 30.21% | 25.49% | 22.09% | 19.27% | |||
All data in USD